Menu
Recruiting NCT07659015

Use of Hand Extension Rubber During Intravenous Catheter Placement

No phase Interventional Pain Anxiety Satisfaction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hand Extension Rubber.
Who it may be relevant to
Registry conditions: Pain, Anxiety, Satisfaction. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Hand Extension Rubber Used in Patients With Peripheral Intravenous Catheter Insertion on Pain, Anxiety and Satisfaction: A Randomized Controlled Trial

Overview

The study aims to investigate the effect of a hand extension rubber used in patients with peripheral intravenous catheters on pain, anxiety, and satisfaction.

Detailed description

While the use of non-pharmacological methods to reduce pain and anxiety levels and increase satisfaction during peripheral intravenous catheterization has gained importance in recent years, studies on techniques that are easy to implement, low-cost, and proven to be effective-particularly in adults-remain limited. It is believed that the hand extension rubber has the potential to reduce pain and anxiety as a distraction method, thereby increasing patient satisfaction. The findings will enhance nurses' adherence to evidence-based practices and improve the quality of patient care. This study holds unique value as it is the first research in Turkey to address this method in adult individuals.

Interventions

  • Other Hand Extension Rubber
    Hand Extension Rubber will be used for distraction while peripheral IV catheher placement.

Primary outcome measures

  • Pain associated with PIC procedure (using VAS-visual analogue scale) [Time frame: after the PIC implementation]
Secondary outcome measures (2)
  • satisfaction associated with PIC procedure (using State-Trait Anxiety Inventory) [Time frame: after the PIC implementation]
  • anxiety associated with PIC procedure (using a five likert type quesiton-) [Time frame: after the PIC implementation]

Eligibility criteria

Inclusion criteria

  • Volunteers willing to participate in the study
  • Patients aged 18-65
  • Patients who are alert and able to communicate verbally in Turkish
  • Patients assigned to the green zone during triage
  • Patients suitable for PICC placement in the left cephalic and basilic veins
  • Patients who are right-handed
  • Patients with a VAS pain score of 0 prior to the PIC procedure

Exclusion criteria

  • Patients with acute or chronic pain
  • Patients with conditions that cause limited mobility, such as muscle disorders or grip dysfunction
  • Patients with peripheral neuropathy, arteriovenous fistula, or bilateral mastectomy
  • Patients with a psychiatric diagnosis (as self-reported)
  • Patients with communication impairments (hearing, speech, and vision)
  • Patients with a history of negative PIC procedure experiences

Terminating Criteria:

  • Participants wishing to withdraw from the study at any stage after giving their consent
  • Failure of the PIC procedure
  • Failure to use the hand extension band until the end of the procedure
  • Occurrence of complications related to the PIC procedure during the procedure

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Basic science

Study locations

Turkey (Türkiye) · 1 center
  • Necmettin Erbakan University — Konya

Identifiers

NCT: NCT07659015 · GB-MK-2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗